ICU Medical Inc

ICUI

Company Profile

  • Business description

    ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

  • Contact

    951 Calle Amanecer
    San ClementeCA92673
    USA

    T: +1 949 366-2183

    E: [email protected]

    https://www.icumed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    15,000

Stocks News & Analysis

stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
stocks

ASX share ticks all the popular thematic boxes

The shares are overvalued as investors are overly excited about defence and gold exposure.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,151.800.100.00%
CAC 408,347.940.740.01%
DAX 4025,333.3887.28-0.34%
Dow JONES (US)49,191.99398.21-0.80%
FTSE 10010,174.9937.640.37%
HKSE26,999.81151.340.56%
NASDAQ23,709.8724.03-0.10%
Nikkei 22554,341.23792.071.48%
NZX 50 Index13,757.71101.660.74%
S&P 5006,963.7413.53-0.19%
S&P/ASX 2008,820.601.20-0.01%
SSE Composite Index4,126.0912.67-0.31%

Market Movers